Last update 15 Jul 2025

Interferon gamma-1a(Asubio Pharma Co. Ltd.)

Overview

Basic Info

Drug Type
Interferons
Synonyms
Biogamma, Interferon-gamma-1a, SUN 4800
+ [1]
Target
IFNGR
Action
stimulants
Mechanism
IFNGR stimulants(Interferon gamma receptor stimulants), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), Immunostimulants
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication-
Inactive Indication
Mycosis Fungoides
Originator Organization
Asubio Pharma Co. Ltd.
Active Organization-
Inactive Organization
Asubio Pharma Co. Ltd.
License Organization-
Drug Highest PhaseWithdrawn
First Approval Date
Japan (01 Jan 1992),
Mycosis Fungoides
Regulation-
Login to view timeline

Structure/Sequence

Related

100 Clinical Results associated with Interferon gamma-1a(Asubio Pharma Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Interferon gamma-1a(Asubio Pharma Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Interferon gamma-1a(Asubio Pharma Co. Ltd.)
Login to view more data
1
Literatures (Medical) associated with Interferon gamma-1a(Asubio Pharma Co. Ltd.)
Oncology reportsQ3 · MEDICINE
Interferon gamma increases the antitumor activity of mitomycin C against human colon cancer cells in vitro and in vivo.
Q3 · MEDICINE
100 Deals associated with Interferon gamma-1a(Asubio Pharma Co. Ltd.)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
L03AB03
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Mycosis Fungoides
Japan
Asubio Pharma Co. Ltd.
01 Jan 1992
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free